Bioavailability of 2 granule formulations (enteric-coated and uncoated) of ridaforolimus versus an enteric-coated tablet formulation in male volunteers
Latest Information Update: 20 Mar 2013
At a glance
- Drugs Ridaforolimus (Primary)
- Indications Soft tissue sarcoma
- Focus Pharmacokinetics
- Sponsors Celerion; Merck & Co
- 20 Mar 2013 New trial record
- 09 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.